Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. DERINOX (naphazoline (nitrate de)/ prednisolone)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

DERINOX (naphazoline (nitrate de)/ prednisolone)

Medicine - Posted on Mar 06 2013 - Updated on Jun 12 2019
Active substance (DCI)
  • naphazoline (nitrate de)
  • prednisolone
history (3)
  • 1/23/13

    DERINOX (naphazoline (nitrate de)/ prednisolone)

    DERINOX (naphazoline (nitrate de)/ prednisolone)
    icône flèche
  • 11/2/11

    DERINOX (naphazoline (nitrate de)/ prednisolone)

    Avis défavorable au maintien du remboursement dans les rhinites Ces vasoconstricteurs ont l’AMM en traitement symptomatique ...
    icône flèche
  • 11/8/06

    DERINOX (naphazoline (nitrate de)/ prednisolone)

    DERINOX (naphazoline (nitrate de)/ prednisolone)
    icône flèche
Technical information
ATC code
  • R01AD52
Manufacturer
THERABEL LUCIEN PHARMA
Presentation

DERINOX, solution pour pulvérisation nasale Flacon de 15 ml avec pompe doseuse (CIP : 353 560-6)

All our publications
    Drug therapy Nose and sinus diseases Paediatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
WMuzjDKGg26Zta1Z